Mallinckrodt MNK14344100: Phase 4 Multicenter randomized double blind placebo controlled pilot study to assess the efficacy and safety of H.P. Acthar Gel in subjects with Pulmonary Sarcoidosis
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
August 15, 2018
End Date
June 21, 2023
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
August 15, 2018
End Date
June 21, 2023